Integrated Filing — IndAS



General information about company

Scrip Code 500201
NSE Symbol INDIAGLYCO
MSEI Symbol NOTLISTED
ISIN INE560A01023
Name of company INDIA GLYCOLS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 07-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 14-05-2026   16:15:00
End date and time of board meeting 14-05-2026   17:25:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 10-02-2026
Indicate Company website link for updated RPT policy of the Company https://www.indiaglycols.com/wp-content/uploads/IGL-RPT-Policy-10_02_2026.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
During the year Company has not made any default on Loans and Debt securities.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 2,36,140.00 9,82,620.00
Other income 3,920.00 4,351.00
Total income 2,40,060.00 9,86,971.00
2 Expenses
(a) Cost of materials consumed 48,466.00 2,41,243.00
(b) Purchases of stock-in-trade 4,025.00 18,846.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 8,351.00 6,092.00
(d) Employee benefit expense 3,368.00 13,069.00
(e) Finance costs 2,641.00 16,718.00
(f) Depreciation, depletion and amortisation expense 4,123.00 15,538.00
(f) Other Expenses
1 Excise Duty 1,38,366.00 5,61,522.00
2 Power and Fuel 8,769.00 40,050.00
3 Other Expenses 8,373.00 37,140.00
Total other expenses 1,55,508.00 6,38,712.00
Total expenses 2,26,482.00 9,50,218.00
3 Total profit before exceptional items and tax 13,578.00 36,753.00
4 Exceptional items 0.00 (83.00)
5 Total profit before tax 13,578.00 36,670.00
6 Tax expense
7 Current tax (913.00) 2,107.00
8 Deferred tax 3,463.00 6,330.00
9 Total tax expenses 2,550.00 8,437.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 11,028.00 28,233.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 11,028.00 28,233.00
17 Other comprehensive income net of taxes (114.00) (170.00)
18 Total Comprehensive Income for the period 10,914.00 28,063.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 3,351.00 3,351.00
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve 0.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 17.31 44.31
Diluted earnings (loss) per share from continuing operations 17.31 44.31
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 17.31 44.31
Diluted earnings (loss) per share from continuing and discontinued operations 17.31 44.31
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Note on Financial Results: Note: At point no.21 'Face value of equity share capital' of Rs.5 is the Face value per equity share. Note on Cash Flow Statement: (1) Since there is no option to fill ‘adjustment for (Profit)/Loss on Sale of Property, plant & equipment’, Govt. Grant and ‘Provision No Longer Required Written Back’ in the utility, the same are shown in 'Other adjustment for non-cash items'. The actual figures (Rs. in crore) are as follows: (a) Adjustment for (Profit)/Loss on Sale of Property, plant & equipment: -1.26 (b) Govt. grant: -0.12 (c) Provision No Longer Required Written Back: -2.28



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4,55,129.00
Capital work-in-progress 3,670.00
Investment property 172.00
Goodwill 0.00
Other intangible assets 146.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 4.00
Trade receivables, non-current 0.00
Loans, non-current 150.00
Other non-current financial assets
1 Other non-current financial assets 4,108.00
Total of other non-current financial assets 4,108.00
Total non-current financial assets 4,262.00
Deferred tax assets (net) 0.00
Other non-current assets
1 Other non-current assets 260.00
Total of other non-current assets 260.00
Total non-current assets 4,63,639.00
2 Current assets
Inventories 88,799.00
Current financial asset
Current investments 0.00
Trade receivables, current 35,266.00
Cash and cash equivalents 3,106.00
Bank balance other than cash and cash equivalents 1,796.00
Loans, current 2,042.00
Other current financial assets
Total of other current financial assets 1,574.00
Total current financial assets 43,784.00
Current tax assets (net) 1,186.00
Other current assets
1 Other current assets 15,204.00
Total of other current assets 15,204.00
Total current assets 1,48,973.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 6,12,612.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 3,351.00
Other equity 2,50,393.00
Total equity attributable to owners of parent 2,53,744.00
Non controlling interest
Total equity 2,53,744.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 91,913.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 14,342.00
Total of other non-current financial liabilities 14,342.00
Total non-current financial liabilities 1,06,255.00
Provisions, non-current 568.00
Deferred tax liabilities (net) 50,511.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 272.00
Total of other non-current liabilities 272.00
Total non-current liabilities 1,57,606.00
Current liabilities
Current financial liabilities
Borrowings, current 65,934.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 17.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 78,771.00
Total Trade payable 78,788.00
Other current financial liabilities
1 Other current financial liabilities 43,081.00
Total of other current financial liabilities 43,081.00
Total current financial liabilities 1,87,803.00
Other current liabilities 12,703.00
1 Other current liabilities 12,703.00
Total of other current liabilities 12,703.00
Provisions, current 756.00
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 2,01,262.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 3,58,868.00
Total equity and liabilites 6,12,612.00
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) Note1: Since there is no option to fill 'Right to use assets' in the utility, the same is clubbed with 'Property, Plant and Equipment'. The actual figures (Rs. in crore) are as follows: (a) Property, Plant and Equipment: 4445.21 (b) Right to use assets: 106.08 Note2: Since there is no option to fill 'Lease Liabilities' in the utility, the same is clubbed with 'Other financial liabilities'.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Bio-based Specialities and Performance Chemicals 30,255.00 1,20,207.00
2 Potable Spirits 1,69,009.00 6,94,643.00
3 Ennature Biopharma 6,349.00 20,777.00
4 Bio-Fuel 30,527.00 1,46,993.00
Total Segment Revenue 2,36,140.00 9,82,620.00
Less: Inter segment revenue 0.00 0.00
Revenue from operations 2,36,140.00 9,82,620.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Bio-based Specialities and Performance Chemicals 3,447.00 13,827.00
2 Potable Spirits 6,778.00 28,493.00
3 Ennature Biopharma 301.00 723.00
4 Bio-Fuel 3,021.00 11,523.00
Total Profit before tax 13,547.00 54,566.00
i. Finance cost 2,641.00 16,718.00
ii. Other Unallocable Expenditure net off Unallocable income (2,672.00) 1,178.00
Profit before tax 13,578.00 36,670.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Bio-based Specialities and Performance Chemicals 3,59,599.00 3,59,599.00
2 Potable Spirits 59,660.00 59,660.00
3 Ennature Biopharma 42,642.00 42,642.00
4 Bio-Fuel 1,42,996.00 1,42,996.00
Total Segment Asset 6,04,897.00 6,04,897.00
Un-allocable Assets 7,715.00 7,715.00
Net Segment Asset 6,12,612.00 6,12,612.00
4 Segment Liabilities
Segment Liabilities
1 Bio-based Specialities and Performance Chemicals 73,705.00 73,705.00
2 Potable Spirits 32,653.00 32,653.00
3 Ennature Biopharma 9,249.00 9,249.00
4 Bio-Fuel 9,227.00 9,227.00
Total Segment Liabilities 1,24,834.00 1,24,834.00
Un-allocable Liabilities 2,34,034.00 2,34,034.00
Net Segment Liabilities 3,58,868.00 3,58,868.00
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) Note1: Since there is no option to fill 'Exceptional Items' in the utility, the same is clubbed with 'Unallocated corporate expenses net of unallocable income'.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit and loss (152.00) (227.00)
Total Amount of items that will not be reclassified to profit and loss (152.00) (227.00)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss (38.00) (57.00)
5 Total Other comprehensive income (114.00) (170.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 36,670.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 16,833.00
Adjustments for decrease (increase) in inventories 28,081.00
Adjustments for decrease (increase) in trade receivables, current 6,962.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (20,369.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 15,538.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 215.00
Adjustments for dividend income 3,858.00
Adjustments for interest income 447.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (366.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 42,589.00
Net cash flows from (used in) operations 79,259.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,360.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 76,899.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment (686.00)
Proceeds from sales of investment property (82,348.00)
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 3,858.00
Interest received 1,106.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (76,698.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 46,699.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 43,831.00
Repayments of borrowings 66,412.00
Payments of lease liabilities (2,488.00)
Dividends paid 7,531.00
Interest paid 16,821.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 2,254.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,455.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 2,455.00
Cash and cash equivalents cash flow statement at beginning of period 651.00
Cash and cash equivalents cash flow statement at end of period 3,106.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 K.N. Gutgutia & Co. Yes 30-11-2027


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 INDIA GLYCOLS LIMITED IGL Finance Limited Subsidiary Company Inter-corporate deposit Not Applicable 0.00 2,042.00 2,042.00 Textual Information(1)
2 INDIA GLYCOLS LIMITED IGL Finance Limited Subsidiary Company Any other transaction Other Receivables 50.00 Yes 0.00 29.00 29.00 Textual Information(2)
3 INDIA GLYCOLS LIMITED IGL Finance Limited Subsidiary Company Investment Not Applicable 0.00 550.00 550.00 Textual Information(3)
4 INDIA GLYCOLS LIMITED IGL Finance Limited Subsidiary Company Any other transaction Provision against Investment Not Applicable 0.00 550.00 550.00
5 INDIA GLYCOLS LIMITED IGL CHEM INTERNATIONAL PTE LTD Subsidiary Company Investment Not Applicable 0.00 27.00 27.00 Textual Information(4)
6 INDIA GLYCOLS LIMITED IGL CHEM INTERNATIONAL PTE LTD Subsidiary Company Any other transaction Provision against Investment Not Applicable 0.00 27.00 27.00
7 INDIA GLYCOLS LIMITED IGL CHEM INTERNATIONAL LLC, USA Subsidiary Company Sale of goods or services 4,000.00 Yes 199.00 262.00 262.00 Textual Information(5)
8 INDIA GLYCOLS LIMITED IGL CHEM INTERNATIONAL LLC, USA Subsidiary Company Investment Not Applicable 0.00 127.00 127.00 Textual Information(6)
9 INDIA GLYCOLS LIMITED IGL CHEM INTERNATIONAL LLC, USA Subsidiary Company Any other transaction Provision against Investment Not Applicable 0.00 127.00 127.00
10 INDIA GLYCOLS LIMITED IGL CHEMICALS AND SERVICES PRIVATE LIMITED Subsidiary Company Investment Not Applicable 0.00 1.00 1.00 Textual Information(7)
11 INDIA GLYCOLS LIMITED IGL CHEMICALS AND SERVICES PRIVATE LIMITED Subsidiary Company Any other transaction Reimbursement of expenses 10.00 Yes 0.00 0.00 0.00 Textual Information(8)
12 INDIA GLYCOLS LIMITED Ennature Bio Pharma Limited Subsidiary Company Investment Not Applicable 0.00 1.00 1.00 Textual Information(9)
13 INDIA GLYCOLS LIMITED Ennature Bio Pharma Limited Subsidiary Company Any other transaction Reimbursement of expenses 10.00 Yes 10.00 0.00 0.00
14 INDIA GLYCOLS LIMITED Ajay Commercial Co. (P) Ltd. Enterprises over which KMP have significant influence (Promoter Group) Any other transaction Security Given Not Applicable 0.00 400.00 400.00
15 INDIA GLYCOLS LIMITED J.B. Commercial Co. (P) Ltd. Enterprises over which KMP have significant influence (Promoter Group) Any other transaction Security Given Not Applicable 0.00 400.00 400.00
16 INDIA GLYCOLS LIMITED Ajay Commercial Co. (P) Ltd. Enterprises over which KMP have significant influence (Promoter Group) Purchase of goods or services 22.00 Yes 4.00 0.00 0.00 Textual Information(10)
17 INDIA GLYCOLS LIMITED J.B. Commercial Co. (P) Ltd. Enterprises over which KMP have significant influence (Promoter Group) Purchase of goods or services 22.00 Yes 4.00 0.00 0.00 Textual Information(11)
18 INDIA GLYCOLS LIMITED Kashipur Holdings Limited Enterprises over which KMP have significant influence (Promoter Group) Purchase of goods or services 21.00 Yes 2.00 0.00 1.00 Textual Information(12)
19 INDIA GLYCOLS LIMITED Hindustan Wires Limited Enterprises over which KMP have significant influence (Promoter Group) Sale of goods or services 3,500.00 Yes 554.00 8.00 110.00 Textual Information(13)
20 INDIA GLYCOLS LIMITED Hindustan Wires Limited Enterprises over which KMP have significant influence (Promoter Group) Purchase of goods or services 50.00 Yes 18.00 0.00 0.00 Textual Information(14)
21 INDIA GLYCOLS LIMITED Hindustan Wires Limited Enterprises over which KMP have significant influence (Promoter Group) Any other transaction Reimbursement of Expenses made 25.00 Yes 1.00 0.00 0.00
22 INDIA GLYCOLS LIMITED Hindustan Wires Limited Enterprises over which KMP have significant influence (Promoter Group) Inter-corporate deposit Not Applicable 3,000.00 (3,000.00) 0.00 Textual Information(15)
23 INDIA GLYCOLS LIMITED Hindustan Wires Limited Enterprises over which KMP have significant influence (Promoter Group) Interest paid Not Applicable 42.00 150.00 0.00
24 INDIA GLYCOLS LIMITED IGL Infrastructure Pvt. Ltd. Enterprises over which KMP have significant influence Any other transaction Reimbursement of Expenses received 200.00 Yes 11.00 0.00 0.00
25 INDIA GLYCOLS LIMITED IGL Infrastructure Pvt. Ltd. Enterprises over which KMP have significant influence Purchase of goods or services 2,276.00 Yes 379.00 0.00 0.00 Textual Information(16)
26 INDIA GLYCOLS LIMITED IGL Infrastructure Pvt. Ltd. Enterprises over which KMP have significant influence Purchase of goods or services Not Applicable 156.00 103.00 98.00 Textual Information(17)
27 INDIA GLYCOLS LIMITED IGL Infrastructure Pvt. Ltd. Enterprises over which KMP have significant influence Any other transaction Security Given Not Applicable 0.00 584.00 584.00
28 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Purchase of goods or services 300.00 Yes 1.00 0.00 0.00 Textual Information(18)
29 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Sale of goods or services 600.00 Yes 17,960.00 2,613.00 1,491.00 Textual Information(19)
30 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Sale of goods or services Not Applicable 270.00 0.00 0.00 Textual Information(20)
31 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Dividend received Not Applicable 3,600.00 0.00 0.00
32 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Any other transaction Reimbursement of expenses made 100.00 Yes 19.00 0.00 0.00
33 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Sale of goods or services Not Applicable 29.00 0.00 0.00 Textual Information(21)
34 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Investment Not Applicable 0.00 1.00 1.00 Textual Information(22)
35 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Purchase of goods or services Not Applicable 3.00 0.00 0.00 Textual Information(23)
36 INDIA GLYCOLS LIMITED Clariant IGL Specialty Chemicals Private Limited Joint Venture Any other transaction Security Deposit Not Applicable 0.00 (2.00) (2.00)
37 INDIA GLYCOLS LIMITED Uma Shankar Bhartia Chairman& Managing Director (Promoter Group) Purchase of goods or services Not Applicable 12.00 0.00 0.00 Textual Information(24)
38 INDIA GLYCOLS LIMITED Uma Shankar Bhartia Chairman& Managing Director (Promoter Group) Remuneration Not Applicable 294.00 0.00 0.00 Textual Information(25)
39 INDIA GLYCOLS LIMITED Uma Shankar Bhartia Chairman& Managing Director (Promoter Group) Remuneration Not Applicable 1,466.00 (585.00) (1,466.00) Textual Information(26)
40 INDIA GLYCOLS LIMITED Uma Shankar Bhartia Chairman& Managing Director (Promoter Group) Any other transaction Security Given Not Applicable 0.00 500.00 500.00
41 INDIA GLYCOLS LIMITED Pragya Bhartia Barwale Executive Director (Promoter Group) Remuneration Not Applicable 60.00 0.00 0.00 Textual Information(27)
42 INDIA GLYCOLS LIMITED Pragya Bhartia Barwale Executive Director (Promoter Group) Remuneration Not Applicable 733.00 (292.00) (733.00) Textual Information(28)
43 INDIA GLYCOLS LIMITED Alok Singhal Executive Director Remuneration Not Applicable 55.00 (4.00) (4.00)
44 INDIA GLYCOLS LIMITED Rupark Sarswat Chief Executive Officer Remuneration Not Applicable 330.00 0.00 0.00
45 INDIA GLYCOLS LIMITED Anand Singhal Chief Financial Officer Remuneration Not Applicable 62.00 (2.00) 0.00
46 INDIA GLYCOLS LIMITED Anand Singhal HUF Relative of KMP Purchase of goods or services 12.00 Yes 6.00 0.00 0.00 Textual Information(29)
47 INDIA GLYCOLS LIMITED Ankur Jain Company Secretary Remuneration Not Applicable 45.00 0.00 0.00
48 INDIA GLYCOLS LIMITED Jayshree Bhartia Non-Executive Director Any other transaction Director Sitting Fees 10.00 Yes 0.00 0.00 0.00
49 INDIA GLYCOLS LIMITED IGL Spirits Limited Subsidiary Company Investment Not Applicable 0.00 1.00 1.00 Textual Information(30)
50 INDIA GLYCOLS LIMITED Ravi Kumar Independent Director Any other transaction Director Sitting Fees Not Applicable 4.00 0.00 0.00
51 INDIA GLYCOLS LIMITED Shukla Wassan Independent Director Any other transaction Director Sitting Fees Not Applicable 2.00 0.00 0.00
52 INDIA GLYCOLS LIMITED SAMRAT BANERJEE Independent Director Any other transaction Director Sitting Fees Not Applicable 4.00 0.00 0.00
53 INDIA GLYCOLS LIMITED SUSHIL DUTT SALWAN Independent Director Any other transaction Director Sitting Fees Not Applicable 2.00 0.00 0.00
54 INDIA GLYCOLS LIMITED Jayshree Bhartia Non-Executive Director Any other transaction Commission Not Applicable 15.00 (12.00) (15.00)
55 INDIA GLYCOLS LIMITED Ravi Kumar Independent Director Any other transaction Commission Not Applicable 25.00 0.00 (25.00)
56 INDIA GLYCOLS LIMITED Shukla Wassan Independent Director Any other transaction Commission Not Applicable 15.00 0.00 (15.00)
57 INDIA GLYCOLS LIMITED SAMRAT BANERJEE Independent Director Any other transaction Commission Not Applicable 15.00 0.00 (15.00)
58 INDIA GLYCOLS LIMITED SUSHIL DUTT SALWAN Independent Director Any other transaction Commission Not Applicable 15.00 0.00 (15.00)
59 INDIA GLYCOLS LIMITED IGL CHEMICALS AND SERVICES PRIVATE LIMITED Subsidiary Company Dividend received Not Applicable 258.00 0.00 0.00
60 INDIA GLYCOLS LIMITED IGL CHEM INTERNATIONAL LLC, USA Subsidiary Company Any other transaction Commission Not Applicable 560.00 0.00 0.00
61 INDIA GLYCOLS LIMITED Kashipur Holdings Limited Enterprises over which KMP have significant influence (Promoter Group) Inter-corporate deposit Not Applicable 1,400.00 0.00 0.00 Textual Information(31)
62 INDIA GLYCOLS LIMITED Kashipur Holdings Limited Enterprises over which KMP have significant influence (Promoter Group) Inter-corporate deposit Not Applicable 1,400.00 0.00 0.00 Textual Information(32)
63 INDIA GLYCOLS LIMITED Kashipur Holdings Limited Enterprises over which KMP have significant influence (Promoter Group) Interest paid Not Applicable 16.00 0.00 0.00
64 INDIA GLYCOLS LIMITED Kashipur Holdings Limited Enterprises over which KMP have significant influence (Promoter Group) Dividend paid Not Applicable 4,061.00 0.00 0.00
65 INDIA GLYCOLS LIMITED Hindustan Wires Limited Enterprises over which KMP have significant influence (Promoter Group) Dividend paid Not Applicable 16.00 0.00 0.00
66 INDIA GLYCOLS LIMITED Uma Shankar Bhartia Chairman& Managing Director (Promoter Group) Dividend paid Not Applicable 112.00 0.00 0.00
67 INDIA GLYCOLS LIMITED Pragya Bhartia Barwale Executive Director (Promoter Group) Dividend paid Not Applicable 0.00 0.00 0.00
68 INDIA GLYCOLS LIMITED Sukhvarsha Distributors Pvt. Ltd Enterprises over which KMP have significant influence (Promoter Group) Dividend paid Not Applicable 90.00 0.00 0.00
69 INDIA GLYCOLS LIMITED Jayshree Bhartia Non-Executive Director Dividend paid Not Applicable 57.00 0.00 0.00
70 INDIA GLYCOLS LIMITED Pooja Jhaver Promoter Group Dividend paid Not Applicable 24.00 0.00 0.00
71 INDIA GLYCOLS LIMITED Executors To The Estate Of Late Sajani Devi Bhartia Promoter Group Dividend paid Not Applicable 525.00 0.00 0.00
72 INDIA GLYCOLS LIMITED Alok Singhal Executive Director Dividend paid Not Applicable 0.00 0.00 0.00
Total value of transaction during the reporting period 37,941.00



Text Block

Textual Information(1) For Column 'I': ICD Receivable
Textual Information(2) For Column 'I': Reimbursement of expenses
Textual Information(3) For Column 'I': Investment in Equity Shares
Textual Information(4) For Column 'I': Investment in Equity Shares
Textual Information(5) For Column 'I': Sale of Material
Textual Information(6) For Column 'I': Investment in Equity Shares
Textual Information(7) For Column 'I': Investment in Equity Shares
Textual Information(8) For Column 'P': 0.001
Textual Information(9) For Column 'I': Investment in Equity Shares
Textual Information(10) For Column 'I': Rent Paid* * Value of approved amount is calculated on the basis of total contract period.
Textual Information(11) For Column 'I': Rent Paid* * Value of approved amount is calculated on the basis of total contract period.
Textual Information(12) For Column 'I': Rent Paid* * Value of approved amount is calculated on the basis of total contract period.
Textual Information(13) For Column 'I': Sale of Material
Textual Information(14) For Column 'I': Legal & Professional fee
Textual Information(15) For Column 'I': ICD paid back
Textual Information(16) For Column 'I': Rent Paid. For Column K: Aggregate of Rs. 2,276 Lakhs is approved for RPT at Sl. No- 25 & 26 for a period of three years.
Textual Information(17) For Column 'I': Office Maint./Electricity Exp. For Column K: Aggregate of Rs. 2,276 Lakhs is approved for RPT at Sl. No- 25 & 26 for a period of three years.
Textual Information(18) For Column 'I': Purchase of material** ** As the value of few transactions are based on formula(s) for long-term contracts, value of approved amount is not ascertainable.
Textual Information(19) For Column 'I': Sale of Material** ** As the value of few transactions are based on formula(s) for long-term contracts, value of approved amount is not ascertainable.
Textual Information(20) For Column 'I': Misc income** ** As the value of few transactions are based on formula(s) for long-term contracts, value of approved amount is not ascertainable.
Textual Information(21) For Column 'I': Rental income** ** As the value of few transactions are based on formula(s) for long-term contracts, value of approved amount is not ascertainable.
Textual Information(22) For Column 'I': Investment in Equity Shares
Textual Information(23) For Column 'I': Rent Paid* * Value of approved amount is calculated on the basis of total contract period.
Textual Information(24) For Column 'I': Rent Paid
Textual Information(25) For Column 'I': Managerial Remuneration
Textual Information(26) For Column 'I': Commission
Textual Information(27) For Column 'I': Managerial Remuneration
Textual Information(28) For Column 'I': Commission
Textual Information(29) For Column 'I': Vehicle Lease Rent
Textual Information(30) For Column 'I': Investment in Equity Shares
Textual Information(31) For Column 'I': ICD Received
Textual Information(32) For Column 'I': ICD Paid Back